By the end of this symposium, participants should be able to
Relate the results from important clinical trials and evidence-based medicine that guide the management of patients with atherosclerosis and structural heart disease
Integrate new interventional techniques and procedures to the care of patients with complex coronary artery disease, peripheral vascular disease, and structural heart disease
Integrate appropriate pharmacological management in the care of patients undergoing diagnostic angiography and interventional therapies before, during, and after catheterization
Distinguish between new interventional technologies and propose their appropriate applications to patients with cardiovascular disease

This Congress is designed for interventional cardiologists, radiologists, clinical cardiologists, basic scientists, vascular medicine specialists, surgeons, and other health care professionals with a special interest in the field of interventional vascular therapy and medicine.

Evaluation by questionnaire will address content, presentation, possible bias, and future educational needs.

This Congress is sponsored by the Chinese Society of Cardiology, Chinese Medical Association, Board of Directors, China Interventional Therapeutics and partially funded through educational grants from commercial supporters. The Chinese Society of Cardiology strives to ensure that its programs are as educational as possible and free from bias. To support this endeavor, CIT director and co-directors create organizing and scientific committees to assist in educational content development and content oversight for live cases, concurrent sessions, case reviews, workshops, and scientific symposia. These sessions are developed without influence from commercial supporters.